[1] | Harvey KF, Pfleger CM, Hariharan IK. The Drosophila mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell, 2003, 114(4): 457-467. | [2] | Piccolo S, Dupont S, Cordenonsi M. The biology of YAP/TAZ: hippo signaling and beyond. Physiol Rev, 2014, 94(4): 1287-1312. | [3] | Hansen CG, Moroishi T, Guan KL. YAP and TAZ: a nexus for Hippo signaling and beyond. Trends Cell Biol, 2015, 25(9): 499-513. | [4] | Harvey K, Tapon N. The Salvador-Warts-Hippo pathway- an emerging tumour-suppressor network. Nat Rev Cancer, 2007, 7(3): 182-191. | [5] | Meng ZP, Moroishi T, Guan KL. Mechanisms of Hippo pathway regulation. Genes Dev, 2016, 30(1): 1-17. | [6] | Huang JB, Wu SA, Barrera J, Matthews K, Pan DJ. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell, 2005, 122(3): 421-434. | [7] | Zanconato F, Cordenonsi M, Piccolo S. YAP/TAZ at the roots of cancer. Cancer Cell, 2016, 29(6): 783-803. | [8] | Zeng Q, Hong WJ. The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals. Cancer Cell, 2008, 13(3): 188-192. | [9] | Zhao B, Wei XM, Li WQ, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu JD, Li L, Zheng P, Ye KQ, Chinnaiyan A, Halder G, Lai ZC, Guan KL. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev, 2007, 21(21): 2747-2761. | [10] | Zhang X, George J, Deb S, Degoutin JL, Takano EA, Fox SB, AOCS Study group, Bowtell DDL, Harvey KF. The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene. Oncogene, 2011, 30(25): 2810-2822. | [11] | Steinhardt AA, Gayyed MF, Klein AP, Dong JX, Maitra A, Pan DJ, Montgomery EA, Anders RA. Expression of Yes-associated protein in common solid tumors. Hum Pathol, 2008, 39(11): 1582-1589. | [12] | Wang KN, Degerny C, Xu MH, Yang XJ. YAP, TAZ, Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease. Biochem Cell Biol, 2009, 87(1): 77-91. | [13] | Zhao B, Ye X, Yu JD, Li L, Li WQ, Li SM, Yu JJ, Lin JD, Wang CY, Chinnaiyan AM, Lai ZC, Guan KL. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev, 2008, 22(14): 1962-1971. | [14] | Chen Q, Zhang NL, Xie R, Wang W, Cai J, Choi KS, David KK, Huang B, Yabuta N, Nojima H, Anders RA, Pan DJ. Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP. Genes Dev, 2015, 29(12): 1285-1297. | [15] | Mao B, Hu F, Cheng J, Wang P, Xu M, Yuan F, Meng S, Wang Y, Yuan Z, Bi W. SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma. Oncogene, 2014, 33(11): 1468-1474. | [16] | Fu D, Lv XM, Hua GH, He CB, Dong JX, Lele SM, Li DWC, Zhai QL, Davis JS, Wang C. YAP regulates cell proliferation, migration, and steroidogenesis in adult granulosa cell tumors. Endocr Relat Cancer, 2014, 21(2): 297-310. | [17] | Cai H, Xu Y. The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells. Cell Commun Signal, 2013, 11(1): 31. | [18] | Zhang JM, Smolen GA, Haber DA. Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway. Cancer Res, 2008, 68(8): 2789-2794. | [19] | Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF β-TRCP. Genes Dev, 2010, 24(1): 72-85. | [20] | Mo JS, Meng ZP, Kim YC, Park HW, Hansen CG, Kim S, Lim DS, Guan KL. Cellular energy stress induces AMPK- mediated regulation of YAP and the Hippo pathway. Nat Cell Biol, 2015, 17(4): 500-510. | [21] | Santinon G, Pocaterra A, Dupont S. Control of YAP/TAZ activity by metabolic and nutrient-sensing pathways. Trends Cell Biol, 2016, 26(4): 289-299. | [22] | Moon S, Kim W, Kim S, Kim Y, Song Y, Bilousov O, Kim J, Lee T, Cha B, Kim M, Kim H, Katanaev VL, Jho EH. Phosphorylation by NLK inhibits YAP-14-3-3-interactions and induces its nuclear localization. EMBO Rep, 2017, 18(1): 61-71. | [23] | Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang CX, Hong WJ. Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem, 2011, 286(9): 7018-7026. | [24] | Zhu C, Li L, Zhao B. The regulation and function of YAP transcription co-activator. Acta Biochim Biophys Sinica (Shanghai), 2015, 47(1): 16-28. | [25] | Lamar JM, Stern P, Liu H, Schindler JW, Jiang ZG, Hynes RO. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain. Proc Natl Acad Sci USA, 2012, 109(37): E2441-E2450. |
|